Screening for and treating MGD to prevent CL drop outs

Article

Kelly Nichols, OD, FAAO, PhD, MPH, Dipl PH, says she would like to see optometrists screen for meibomian gland dysfunction during eye exams and consider the condition when treating patients who are experiencing discomfort with their contact lenses.

Atlanta, GA-Kelly Nichols, OD, FAAO, PhD, MPH, Dipl PH, says she would like to see optometrists screen for meibomian gland dysfunction during eye exams and consider the condition when treating patients who are experiencing discomfort with their contact lenses.

“As a profession, we are poised to be preventative, but we tend to be reactive,” says Dr. Nichols.

Contact lens patients cite dryness and discomfort as the main reasons for decreasing or discontinuing their use of lenses. Dr. Nichols says MGD may be the leading cause of dry eye disease throughout the world.

How many people have MGD? Dr. Nichols says that answer has varied drastically-as low as 3.5% to as high as 69.5%-based on the sample and the definition of MGD used. Asian countries have reported a higher prevalence-as high as 65%-but Dr. Nichols says it is unknown if it is ethnicity related.

When ODs are working with a patient with lens discomfort, they often choose to refit the patient with a lens in a different material, recommend rewetting drops or lubricants, or change the care solutions. If the discomfort persists even after removing the lenses, Dr. Nichols says she would like to see doctors addressing the underlying condition because contact lenses can cause MGD, and MGD can cause discomfort for contact lens wearers.

 Dr. Nichols says eyecare practioners should recommend warm compress therapy twice a day for 2 weeks. She says doctors should also consider recommending omega-3s and prescribing Restasis (cyclosporin, Allergan). 

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Erin Tomiyama, OD, PhD, FAAO, discusses fitting lenses, young adults with binocular vision issues, and emerging presbyopia in patients.
Dr. Lisa Hornick goes over cosmetic habits and digital eye strain factors in OSD
© 2024 MJH Life Sciences

All rights reserved.